In summary, our study provided evidence in support of the suppressive effects of BMSC‐EV‐derived let‐7i on the development of lung cancer cells through FXYD3 down‐regulation by increasing DCLK1 via KDM3A inhibition. The gene discussed is FXYD3; the disease is lung cancer.